STOCK TITAN

UBS ETRACS Alerian MLP ETN Series B SEC Filings

AMUB NYSE

Welcome to our dedicated page for UBS ETRACS Alerian MLP ETN Series B SEC filings (Ticker: AMUB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The ETRACS Alerian MLP Index ETN Series B due July 18, 2042 (AMUB) is issued by UBS AG, a foreign private issuer that reports to the US Securities and Exchange Commission. UBS AG indicates that it files a registration statement on Form F-3, including a prospectus and supplements, for offerings of securities related to ETRACS ETNs such as AMUB. These documents set out the terms of the ETN and include a "Risk Factors" section that UBS urges investors to review before investing.

UBS AG also submits annual reports on Form 20-F and periodic reports on Form 6-K. In its Form 6-K filings, UBS provides information on capitalization, total debt issued, equity and other capital and liquidity metrics, as well as updates on regulatory developments and other corporate matters. UBS AG notes that its consolidated financial statements are prepared in accordance with IFRS Accounting Standards, and that certain 6-K reports are incorporated by reference into its Form F-3 registration statement.

For AMUB, the relevant SEC filings include the base prospectus, prospectus supplements and any pricing supplements that describe the specific terms of the ETRACS Alerian MLP Index ETN Series B. UBS’s public materials state that these offering documents are available through the SEC’s EDGAR system. They also clarify that the securities related to the offerings are not deposit liabilities and are not insured or guaranteed by the Federal Deposit Insurance Corporation or any other governmental agency of the United States, Switzerland or any other jurisdiction.

On this page, users can access AMUB-related SEC filings and associated issuer reports. The platform provides real-time updates from EDGAR and AI-powered summaries that explain the key points of lengthy documents, such as registration statements, prospectus supplements and UBS AG’s periodic reports. This allows investors to quickly identify disclosures that affect AMUB, including risk factor updates, capital and funding information, and other details relevant to UBS AG’s role as issuer of this senior unsecured ETN.

Rhea-AI Summary

UBS AG is offering $175,000 of Trigger Autocallable Contingent Yield Notes linked to the common stock of NVIDIA Corporation, with principal at risk through July 12, 2027. These unsecured debt notes can pay contingent coupons only on dates when NVIDIA’s closing share price is at or above a preset coupon barrier; if the share price is below that level, no coupon is paid for that period.

The notes are automatically called early if NVIDIA’s closing price on any observation date before maturity is at or above the initial level, in which case investors receive the $10 principal per Note plus any due coupon and the product terminates. If the notes are not called and NVIDIA’s final share price is at or above a downside threshold on the final valuation date, UBS repays principal at maturity; if it is below that threshold, repayment is reduced in line with the stock’s decline and investors can lose all of their investment.

The notes are senior unsecured obligations of UBS, so all payments depend on UBS’s creditworthiness. They are not listed on any exchange, have an estimated initial value of $9.78 per $10 Note, and are offered in minimum investments of 100 Notes ($1,000) and integral multiples of $10 above that amount.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Filing
Rhea-AI Summary

UBS AG is offering $110,000 of Trigger Autocallable Contingent Yield Notes linked to the common stock of Moderna, Inc., maturing on January 12, 2028. These unsecured debt notes pay a contingent coupon only if Moderna’s share price on each observation date is at or above a preset coupon barrier; if it is below, no coupon is paid for that period.

The notes are automatically called early if Moderna’s stock closes at or above the initial level on any observation date before maturity, in which case investors receive the $10 principal per Note plus the applicable coupon, and the product terminates. If not called, principal is repaid at maturity only if the final stock level is at or above a downside threshold; if the final level is below this threshold, repayment is reduced in line with the stock’s percentage loss and can fall to zero.

The term sheet shows a hypothetical contingent coupon rate of 27.05% per annum, with a downside threshold and coupon barrier both at $60.00, or 60% of the initial level. The minimum investment is 100 Notes at $10 each, and the estimated initial value is $9.70 per Note. All payments depend on UBS’s creditworthiness, and the notes will not be listed on any exchange.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

UBS AG is offering $300,000 of Trigger Autocallable Contingent Yield Notes linked to Vistra Corp. common stock, which combine contingent income with equity-like downside risk. Investors receive a coupon only if Vistra’s share price on quarterly observation dates is at or above a preset coupon barrier; otherwise no coupon is paid for that period. The notes can be called early if the share price is at or above the initial level, in which case investors receive principal plus any due coupon and the product terminates.

If the notes are not called and Vistra’s final share price is at or above the downside threshold, principal is repaid at maturity; if it is below, repayment is reduced in line with the stock’s decline and losses can reach 100% of the investment. All payments depend on UBS’s credit, the notes are not listed, and the estimated initial value is $9.71 per $10 note, below the issue price.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
Rhea-AI Summary

UBS AG is offering Trigger Autocallable Contingent Yield Notes linked to NVIDIA Corporation’s common stock, maturing on or about July 12, 2027. Each Note has a $10 principal amount and is expected to settle on January 12, 2026, with a term of about 18 months. Investors may receive contingent coupons only when NVIDIA’s closing price on an observation date is at or above a preset coupon barrier; no coupon is paid if it falls below this level.

The Notes are automatically called early if NVIDIA’s price on any observation date before maturity is at or above the initial level, paying back principal plus the applicable contingent coupon and ending the investment. If the Notes are not called and NVIDIA’s final level is at or above the downside threshold, investors receive their $10 principal at maturity, potentially with a final coupon. If the final level is below the downside threshold, repayment is reduced in line with NVIDIA’s decline, which can result in a total loss of principal. Payments depend on UBS’s credit, the Notes will not be listed on an exchange, and the estimated initial value is between $9.44 and $9.69 per $10 Note.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

UBS AG is offering Trigger Autocallable Contingent Yield Notes linked to the common stock of Moderna, Inc., maturing on or about January 12, 2028. Each Note has a $10 principal amount, with a minimum investment of 100 Notes, and pays a contingent coupon only if Moderna’s closing share price on an observation date is at or above a preset coupon barrier.

The Notes are automatically called if, on any observation date before the final valuation date, the stock closes at or above the initial level, in which case investors receive principal plus the due contingent coupon and no further payments. If the Notes are not called and the final stock level is at or above the downside threshold, investors receive full principal at maturity, plus a contingent coupon if the coupon barrier is met. If the final level is below the downside threshold, repayment of principal is reduced in line with the stock’s loss, and investors could lose their entire investment.

The Notes are unsecured, unsubordinated obligations of UBS; all payments depend on UBS’s credit. They will not be listed on an exchange, and the estimated initial value is expected to be between $9.40 and $9.65 per $10 Note.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

UBS AG is offering unsecured Trigger Autocallable Contingent Yield Notes linked to the common stock of Vistra Corp., maturing on or about January 12, 2029. These notes pay a contingent coupon only on observation dates when Vistra’s stock closes at or above a preset coupon barrier; if the stock is below that level, no coupon is paid for that period.

The notes are automatically called early if, on any quarterly observation date before maturity, Vistra’s stock closes at or above the initial level. In that case, investors receive the principal plus any due contingent coupon, and the product terminates. If the notes are not called and, at maturity, Vistra’s stock is at or above a downside threshold, investors receive their full principal; if it is below that threshold, repayment is reduced in line with the stock’s decline and losses can reach 100% of principal. Any payment depends on the creditworthiness of UBS. The notes are not listed, have a minimum investment of 100 notes at $10 each, and have an estimated initial value between $9.35 and $9.60 per $10 note.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
Rhea-AI Summary

UBS AG is offering $100,000 of Trigger Autocallable Contingent Yield Notes linked to the common stock of Marvell Technology, Inc., maturing on January 12, 2029. Each Note has a principal amount of $10, with a minimum investment of 100 Notes ($1,000). UBS pays a contingent coupon only if the Marvell share price on an observation date is at or above a preset coupon barrier; otherwise no coupon is paid for that period.

The Notes are automatically called early if, on any monthly observation date after three months and before final valuation, the share price is at or above the initial level. In that case, investors receive principal plus the applicable contingent coupon and no further payments. If the Notes are not called and the final share price is at or above the downside threshold, investors receive principal back at maturity; if it is below the threshold, repayment is reduced in line with the stock decline and can fall to zero.

The Notes are unsecured, unsubordinated obligations of UBS, so all payments depend on UBS’s credit. They are not bank deposits, are not FDIC-insured, will not be listed on an exchange, and the estimated initial value per $10 Note is $9.65, reflecting UBS’s internal pricing models and funding costs.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

UBS AG is offering Trigger Autocallable Contingent Yield Notes linked to the common stock of Marvell Technology, Inc., maturing around January 12, 2029. These are unsecured, unsubordinated debt obligations of UBS, not bank deposits and not FDIC insured.

Holders may receive periodic contingent coupons only if the stock closes at or above a coupon barrier on monthly observation dates. The notes can be automatically called after three months if the stock closes at or above its initial level, in which case investors receive the $10 principal per note plus any due coupon and no further payments.

If not called and the final stock level is at or above a downside threshold, investors receive the $10 principal at maturity, potentially with a final coupon. If the final level is below the downside threshold, repayment is reduced in line with the stock’s decline, and investors can lose all of their initial investment. All payments depend on UBS’s creditworthiness. The minimum investment is 100 notes at $10 each, and the estimated initial value per note is expected to be between $9.35 and $9.60.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

UBS AG is offering $100,000 of Trigger Autocallable Contingent Yield Notes linked to the common stock of Advanced Micro Devices, Inc., maturing on January 12, 2028. These unsecured debt notes pay a contingent coupon only if AMD’s closing level on each observation date is at or above a coupon barrier set at 70% of the initial level; otherwise no coupon is paid.

The notes are automatically called if AMD is at or above its initial level on any observation date before maturity, returning principal plus the applicable contingent coupon, with no further payments. If not called, investors receive full principal at maturity only if AMD’s final level is at or above the downside threshold, also 70% of the initial level. If AMD finishes below that threshold, repayment is reduced in line with AMD’s negative return, and investors can lose all of their investment.

The hypothetical contingent coupon rate is 21.19% per annum100 notes at $10 each. The estimated initial value is $9.75 per $10 note, and all payments depend on the creditworthiness of UBS. The notes will not be listed on any exchange.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
Rhea-AI Summary

UBS AG is offering Trigger Autocallable Contingent Yield Notes linked to the common stock of Advanced Micro Devices, Inc., maturing on or about January 12, 2028. These unsecured debt notes may pay a contingent coupon on each observation date only if AMD’s share price is at or above a preset coupon barrier; otherwise no coupon is paid for that period. The notes are automatically called early if AMD’s share price on any observation date before maturity is at or above the initial level, in which case investors receive principal plus the applicable coupon and no further payments.

If the notes are not called and AMD’s final share price is at or above the downside threshold, investors receive their full principal at maturity, potentially with a final coupon. If the final price is below the downside threshold, repayment is reduced in line with AMD’s decline, and all principal can be lost. All payments depend on the creditworthiness of UBS, and the notes will not be listed on any exchange.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus

FAQ

What is the current stock price of UBS ETRACS Alerian MLP ETN Series B (AMUB)?

The current stock price of UBS ETRACS Alerian MLP ETN Series B (AMUB) is $20.28 as of February 2, 2026.
UBS ETRACS Alerian MLP ETN Series B

NYSE:AMUB

AMUB Rankings

AMUB Stock Data

2.60M

AMUB RSS Feed